Victory Capital Management’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $64.8M | Sell |
396,245
-250,469
| -39% | -$38.5M | 0.04% | 428 |
|
|
2025
Q4 | $113M | Buy |
646,714
+291,807
| +82% | +$53.2M | 0.06% | 279 |
|
|
2025
Q3 | $51.1M | Buy |
354,907
+172,134
| +94% | +$21.1M | 0.03% | 550 |
|
|
2025
Q2 | $18.4M | Sell |
182,773
-226,341
| -55% | -$17.3M | 0.01% | 903 |
|
|
2025
Q1 | $31.2M | Sell |
409,114
-1,463
| -0.4% | -$112K | 0.03% | 645 |
|
|
2024
Q4 | $28.3M | Sell |
410,577
-45,382
| -10% | -$3.27M | 0.03% | 706 |
|
|
2024
Q3 | $33.3M | Buy |
455,959
+308,819
| +210% | +$22.8M | 0.03% | 634 |
|
|
2024
Q2 | $9.86M | Buy |
147,140
+128,098
| +673% | +$4.97M | 0.01% | 1080 |
|
|
2024
Q1 | $517K | Buy |
19,042
+245
| +1% | +$6.86K | ﹤0.01% | 1974 |
|
|
2023
Q4 | $583K | Buy |
18,797
+3,311
| +21% | +$85.9K | ﹤0.01% | 1955 |
|
|
2023
Q3 | $391K | Buy |
15,486
+948
| +7% | +$21.7K | ﹤0.01% | 2052 |
|
|
2023
Q2 | $307K | Sell |
14,538
-339
| -2% | -$6.43K | ﹤0.01% | 2109 |
|
|
2023
Q1 | $254K | Sell |
14,877
-191
| -1% | -$3.71K | ﹤0.01% | 2193 |
|
|
2022
Q4 | $301K | Sell |
15,068
-22,373
| -60% | -$432K | ﹤0.01% | 2172 |
|
|
2022
Q3 | $807K | Buy |
37,441
+23,840
| +175% | +$572K | ﹤0.01% | 1830 |
|
|
2022
Q2 | $268K | Buy |
13,601
+146
| +1% | +$3.06K | ﹤0.01% | 2269 |
|
|
2022
Q1 | $296K | Sell |
13,455
-494
| -4% | -$11.5K | ﹤0.01% | 2301 |
|
|
2021
Q4 | $380K | Sell |
13,949
-54
| -0.4% | -$1.54K | ﹤0.01% | 2300 |
|
|
2021
Q3 | $386K | Sell |
14,003
-1,020
| -7% | -$26.8K | ﹤0.01% | 2296 |
|
|
2021
Q2 | $428K | Buy |
15,023
+2,972
| +25% | +$88.2K | ﹤0.01% | 2276 |
|
|
2021
Q1 | $410K | Buy |
12,051
+276
| +2% | +$10.5K | ﹤0.01% | 2285 |
|
|
2020
Q4 | $392K | Buy |
11,775
+644
| +6% | +$23.5K | ﹤0.01% | 2185 |
|
|
2020
Q3 | $358K | Sell |
11,131
-1,440
| -11% | -$41.4K | ﹤0.01% | 2098 |
|
|
2020
Q2 | $346K | Sell |
12,571
-9,511
| -43% | -$225K | ﹤0.01% | 2119 |
|
|
2020
Q1 | $354K | Buy |
22,082
+8,092
| +58% | +$192K | ﹤0.01% | 2201 |
|
|
2019
Q4 | $334K | Buy |
13,990
+2,683
| +24% | +$54.6K | ﹤0.01% | 2169 |
|
|
2019
Q3 | $199K | Buy |
+11,307
| New | +$218K | ﹤0.01% | 2222 |
|
|
2018
Q2 | – | Sell |
-589,460
| Closed | -$13.3M | – | 1840 |
|
|
2018
Q1 | $13.3M | Sell |
589,460
-8,790
| -1% | -$231K | 0.03% | 683 |
|
|
2017
Q4 | $18.7M | Buy |
598,250
+22,660
| +4% | +$669K | 0.04% | 597 |
|
|
2017
Q3 | $18M | Buy |
575,590
+541,270
| +1,577% | +$10.3M | 0.04% | 613 |
|
|
2017
Q2 | $589K | Sell |
34,320
-480
| -1% | -$8.2K | ﹤0.01% | 1280 |
|
|
2017
Q1 | $609K | Buy |
+34,800
| New | +$537K | ﹤0.01% | 1269 |
|
Other funds holding INSM
DGM
VPM
VCM
BBA
Victory Capital Management's INSM Position: Q1 2026 in Review
Victory Capital Management reduced its Insmed (INSM) stake by 39% in Q1 2026, selling an estimated $38.5M and leaving 396,245 shares worth $64.8M. The position accounts for 0.04% of the portfolio, ranked #428.
Victory Capital Management first reported a position in INSM in Q1 2017 and has held it in 32 quarters since. The position peaked at $113M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.
- Victory Capital Management held 396,245 shares of Insmed worth $64.8M as of Q1 2026.
- Victory Capital Management sold 250,469 Insmed shares in Q1 2026, an estimated $38.5M.
- Insmed made up 0.04% of Victory Capital Management's portfolio in Q1 2026, its #428 holding.
- Victory Capital Management first reported a position in Insmed in Q1 2017 and has held it in 32 quarters since.
- Victory Capital Management's Insmed position peaked at $113M in Q4 2025.
- 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.
Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.